Caption Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$628K Sell
10,000
-187,000
-95% -$13M ﹤0.01% 1152
2025
Q4
$13.1M Sell
197,000
-253,400
-56% -$16.4M 0.09% 262
2025
Q3
$30.3M Buy
450,400
+413,500
+1,121% +$32.7M 0.24% 87
2025
Q2
$3.22M Buy
36,900
+10,000
+37% +$784K 0.04% 553
2025
Q1
$1.84M Sell
26,900
-128,100
-83% -$10.5M 0.02% 709
2024
Q4
$12.1M Buy
155,000
+120,000
+343% +$8.88M 0.11% 150
2024
Q3
$2.35M Sell
35,000
-200
-0.6% -$16.4K 0.04% 516
2024
Q2
$3.99M Hold
35,200
0.06% 320
2024
Q1
$4.88M Sell
35,200
-225,000
-86% -$28.3M 0.07% 305
2023
Q4
$32.3M Buy
260,200
+202,500
+351% +$20.7M 0.44% 40
2023
Q3
$5.38M Sell
57,700
-30,000
-34% -$3.38M 0.08% 297
2023
Q2
$11.3M Buy
+87,700
New +$10.6M 0.2% 130
2023
Q1
Sell
-262,900
Closed -$29.8M 1199
2022
Q4
$29.8M Buy
262,900
+232,900
+776% +$25.6M 0.46% 41
2022
Q3
$2.42M Buy
+30,000
New +$2.54M 0.03% 578
2022
Q2
Sell
-30,400
Closed -$3.89M 1534
2022
Q1
$3.89M Hold
30,400
0.05% 526
2021
Q4
$4.08M Buy
+30,400
New +$4.37M 0.05% 527
2021
Q3
Sell
-32,000
Closed -$3.42M 1583
2021
Q2
$3.42M Sell
32,000
-128,000
-80% -$12.3M 0.04% 495
2021
Q1
$14.4M Buy
160,000
+60,000
+60% +$5.63M 0.31% 62
2020
Q4
$9.24M Buy
100,000
+60,000
+150% +$5.36M 0.21% 134
2020
Q3
$4.12M Hold
40,000
0.1% 251
2020
Q2
$4.05M Buy
+40,000
New +$3.58M 0.14% 202
2020
Q1
Sell
-680,000
Closed -$37.2M 904
2019
Q4
$37.2M Buy
+680,000
New +$32.3M 1.25% 7

Other funds holding DXCM

Caption Management's DXCM Position: Q1 2026 in Review

Caption Management reduced its DexCom (DXCM) stake by 67% in Q1 2026, selling an estimated $2.35M and leaving 16,316 shares worth $1.02M. The position accounts for 0.01% of the portfolio, ranked #1020.

Caption Management first reported a position in DXCM in Q4 2019 and has held it in 17 quarters since. The position peaked at $7.45M in Q1 2021. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Caption Management held 16,316 shares of DexCom worth $1.02M as of Q1 2026.
  • Caption Management sold 33,684 DexCom shares in Q1 2026, an estimated $2.35M.
  • DexCom made up 0.01% of Caption Management's portfolio in Q1 2026, its #1020 holding.
  • Caption Management first reported a position in DexCom in Q4 2019 and has held it in 17 quarters since.
  • Caption Management's DexCom position peaked at $7.45M in Q1 2021.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.